The TARGET BP OFF-MED Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.
Also called NCT03503773
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT03503773
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, France, Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03503773. Randomized; double masking; primary purpose treatment. Start 2018-09-24 (actual); primary completion 2022-01-31 (actual). Results posted on 2024-10-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The TARGET BP OFF-MED Trial
- Condition
- Hypertension
- Condition
- Hypertension,Essential
- Intervention (Drug)
- Alcohol
- Intervention (Other)
- Sham control
- Lead sponsor
- Ablative Solutions, Inc.
Record details
- Record id
cardio:ct-nct03503773- Content hash
b6d30b5ff5e4c8900c4b5ceef4ee8b3a94c9e42c5648275a493b81bdcca5b714